Zamri H, Mohd Ali M, Shaari A, Mohd Mazalan N, Ahmad N, Nor Amdan N
MethodsX. 2025; 14:103167.
PMID: 39897649
PMC: 11782592.
DOI: 10.1016/j.mex.2025.103167.
Wale Y, Roberts J, Sime F
Antibiotics (Basel). 2025; 13(12.
PMID: 39766591
PMC: 11672834.
DOI: 10.3390/antibiotics13121201.
Kembou-Ringert J, Readman J, Smith C, Breuer J, Standing J
J Antimicrob Chemother. 2022; 78(1):8-20.
PMID: 36411255
PMC: 9780528.
DOI: 10.1093/jac/dkac394.
Hou Y, Mi K, Sun L, Zhou K, Wang L, Zhang L
Pharmaceutics. 2022; 14(7).
PMID: 35890380
PMC: 9316653.
DOI: 10.3390/pharmaceutics14071485.
Singh D, Deosarkar S, Cadogan E, Flemington V, Bray A, Zhang J
PLoS Biol. 2022; 20(5):e3001624.
PMID: 35617197
PMC: 9135222.
DOI: 10.1371/journal.pbio.3001624.
Antibacterial pathway of cefquinome against Staphylococcus aureus based on label-free quantitative proteomics analysis.
Gao L, Zhu H, Chen Y, Yang Y
J Microbiol. 2021; 59(12):1112-1124.
PMID: 34751907
DOI: 10.1007/s12275-021-1201-x.
Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the β-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282.
ODonnell J, Tanudra A, Chen A, Hines D, Tommasi R, Mueller J
ACS Infect Dis. 2020; 6(6):1378-1388.
PMID: 32379415
PMC: 7297445.
DOI: 10.1021/acsinfecdis.0c00019.
Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an Pharmacodynamic Model.
Montero M, Domene Ochoa S, Lopez-Causape C, VanScoy B, Luque S, Sorli L
Antimicrob Agents Chemother. 2020; 64(4).
PMID: 32041712
PMC: 7179322.
DOI: 10.1128/AAC.02542-19.
Generating Robust and Informative Nonclinical and Bacterial Infection Model Efficacy Data To Support Translation to Humans.
Bulitta J, Hope W, Eakin A, Guina T, Tam V, Louie A
Antimicrob Agents Chemother. 2019; 63(5).
PMID: 30833428
PMC: 6496039.
DOI: 10.1128/AAC.02307-18.
Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis.
Bulitta J, Jiao Y, Drescher S, Oliver A, Louie A, Moya B
Clin Pharmacokinet. 2018; 58(2):143-156.
PMID: 29936678
DOI: 10.1007/s40262-018-0678-x.
Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model.
Wu J, Racine F, Wismer M, Young K, Carr D, Xiao J
Antimicrob Agents Chemother. 2018; 62(5).
PMID: 29507068
PMC: 5923117.
DOI: 10.1128/AAC.02323-17.
Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.
Dalhoff A, Schubert S, Vente A
Antimicrob Agents Chemother. 2017; 61(5).
PMID: 28193648
PMC: 5404535.
DOI: 10.1128/AAC.02446-16.
A Diffusion-Based and Dynamic 3D-Printed Device That Enables Parallel in Vitro Pharmacokinetic Profiling of Molecules.
Lockwood S, Meisel J, Monsma Jr F, Spence D
Anal Chem. 2016; 88(3):1864-70.
PMID: 26727249
PMC: 5296943.
DOI: 10.1021/acs.analchem.5b04270.
New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms.
Haagensen J, Verotta D, Huang L, Spormann A, Yang K
Antimicrob Agents Chemother. 2015; 59(7):4074-81.
PMID: 25918138
PMC: 4468651.
DOI: 10.1128/AAC.05037-14.
Pharmacokinetics and pharmacodynamics of nemonoxacin against Streptococcus pneumoniae in an in vitro infection model.
Liang W, Chen Y, Cao Y, Liu X, Huang J, Hu J
Antimicrob Agents Chemother. 2013; 57(7):2942-7.
PMID: 23587953
PMC: 3697386.
DOI: 10.1128/AAC.01098-12.
Activity of moxifloxacin, imipenem, and ertapenem against Escherichia coli, Enterobacter cloacae, Enterococcus faecalis, and Bacteroides fragilis in monocultures and mixed cultures in an in vitro pharmacokinetic/pharmacodynamic model simulating....
Schubert S, Dalhoff A
Antimicrob Agents Chemother. 2012; 56(12):6434-6.
PMID: 23070164
PMC: 3497186.
DOI: 10.1128/AAC.00872-12.
Comparative pharmacokinetics of cefuroxime lysine after single intravenous, intraperitoneal, and intramuscular administration to rats.
Zhao L, Yin R, Wei B, Li Q, Jiang Z, Chen X
Acta Pharmacol Sin. 2012; 33(11):1348-52.
PMID: 23064723
PMC: 4011349.
DOI: 10.1038/aps.2012.99.
In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB.
Vaddady P, Lee R, Meibohm B
Future Med Chem. 2011; 2(8):1355-69.
PMID: 21359155
PMC: 3042695.
DOI: 10.4155/fmc.10.224.
Simplified dosing of gentamicin for treatment of sepsis in Bangladeshi neonates.
Hossain M, Chowdhury N, Shirin M, Saha S, Miller-Bell M, Edwards D
J Health Popul Nutr. 2009; 27(5):640-5.
PMID: 19902799
PMC: 2928089.
DOI: 10.3329/jhpn.v27i5.3640.
A simple in vitro PK/PD model system to determine time-kill curves of drugs against Mycobacteria.
Budha N, Lee R, Hurdle J, Lee R, Meibohm B
Tuberculosis (Edinb). 2009; 89(5):378-85.
PMID: 19748318
PMC: 2783979.
DOI: 10.1016/j.tube.2009.08.002.